Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over ...

A sleep specialist and an endocrinologist discuss ways to engage patients in difficult conversations and shared decision-making to better manage the related conditions of sleep apnea and obesity.

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic headwinds. A key catalyst was last week’s announcement from rival Eli Lilly LLY, ...

The researchers called for further study to understand the mechanism of the relationship between obesity and ICI outcomes.